0001938569 2026-07-31 2026-07-31 true 0001938569 8-K/A 2026-07-31 PALOMINO LABORATORIES INC. DE 000-56582 88-1619619 130 Castilian Drive Suite 102 Goleta CA 93117 (704) 756-2981 false false false false true false On August 5, 2026, Palomino Laboratories Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) disclosing, among other things, the consummation of the Company’s acquisition of Vega Links, Inc., a Delaware corporation (“Vega Links”), pursuant to that certain Share Exchange Agreement and Plan of Reorganization, dated July 31, 2026, by and among the Company, Vega Links and the stockholders of Vega Links (the “Share Exchange Agreement”). Pursuant to the Share Exchange Agreement, the Company acquired all of the issued and outstanding shares of common stock of Vega Links in exchange for an aggregate of 4,472,000 shares of the Company’s common stock (the “Share Exchange”). Following the consummation of the Share Exchange, Vega Links became a wholly owned subsidiary of the Company.This Amendment No. 1 to the Original Report (this “Amendment”) is being filed to amend and supplement Item 9.01 of the Original Report to provide the historical audited financial statements of Vega Links and the unaudited pro forma condensed combined financial information of the Company and Vega Links required by Item 9.01 of Form 8-K.Except as expressly set forth herein, this Amendment does not amend or otherwise modify the disclosures contained in the Original Report. This Amendment should be read in conjunction with the Original Report.